Technology Evolution: Is It Survival of the Fittest?

New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 28; no. 27; pp. 4275 - 4279
Main Authors:	ZIETMAN, Anthony, GOITEIN, Michael, TEPPER, Joel E
Format:	Journal Article
Language:	English
Published:	Alexandria, VA American Society of Clinical Oncology 20-09-2010
Subjects:	Biological and medical sciences Clinical Trials as Topic Cost Control Diffusion of Innovation Equipment Design Evidence-Based Medicine Health Care Costs Humans Medical sciences Patient Selection Protons - therapeutic use Radiotherapy - economics Radiotherapy - instrumentation Technology Transfer Treatment Outcome Tumors Evolution Cancerology Technology Survival
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	New technologies are constantly being developed and introduced into medical practice. Their potential or actual use raises questions of efficacy and cost. All too often financial considerations of profit primarily determine whether a technology will be adopted. In an era in which the need to control costs has become clear, this situation is undesirable. The assessment of efficacy can, however, be very difficult, and the control of financial aspects is likewise problematic. In this article, we address these problems and suggest potential solutions, using proton radiotherapy as an example that may be relevant to the development of other medical devices.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0732-183X 1527-7755
DOI:	10.1200/JCO.2010.29.4645